Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2017

01-11-2017 | Clinical trial

Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography

Authors: Kathleen Van Dyk, Aimee M. Hunter, Linda Ercoli, Laura Petersen, Andrew F. Leuchter, Patricia A. Ganz

Published in: Breast Cancer Research and Treatment | Issue 1/2017

Login to get access

Abstract

Purpose

Targeted methods for evaluating cognitive dysfunction in breast cancer survivors are needed to effectively address this important survivorship issue. To address this need, we examined the validity of a self-report instrument (The functional assessment of cancer therapy: cognitive function; FACT-Cog) regarding correspondence with neuropsychological performance versus depression and evaluated neurophysiological biomarkers of cognition and depressed mood in a sample of breast cancer survivors several years from diagnosis.

Methods

This is a cross-sectional study sample from the prospective observational Mind Body Study. Recruited participants were breast cancer survivors at least 3 years from cancer diagnosis who were part of a longitudinal cohort, and were without current psychiatric disorder or history of a neurological or cognitive disorder at baseline (after completion of primary cancer treatment). Exploratory analysis of the FACT-Cog and quantitative electroencephalography (qEEG) were conducted, with respect to their association with neuropsychological domain scores and depressive symptoms as measured by the Beck Depression Inventory, 2nd edition (BDI-II).

Results

Self-reported cognitive abilities and the impact of cognitive dysfunction on quality of life were associated with memory function in addition to depressive symptoms in our sample of breast cancer survivors. qEEG measures exhibit differential patterns of association with neuropsychological performance and mood.

Conclusions

Our findings indicate that perceived cognitive abilities and the impact of cognitive difficulties on quality of life are valid indicators of objective cognitive function, independent of depressive symptoms. Neurophysiological correlates of cognitive function and depressive symptoms represent promising biomarkers of these behavioral difficulties in survivorship.
Literature
2.
go back to reference Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DH, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR (2013) Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 105:791–801CrossRefPubMedPubMedCentral Ganz PA, Kwan L, Castellon SA, Oppenheim A, Bower JE, Silverman DH, Cole SW, Irwin MR, Ancoli-Israel S, Belin TR (2013) Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance. J Natl Cancer Inst. 105:791–801CrossRefPubMedPubMedCentral
5.
go back to reference Wagner LI, Sweet J, Butt Z, J-s Lai, Cella D (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7(6):W32–W39 Wagner LI, Sweet J, Butt Z, J-s Lai, Cella D (2009) Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol 7(6):W32–W39
6.
go back to reference Wechsler D (2001) Wechsler Test of Adult Reading: WTAR. Psychological Corporation Wechsler D (2001) Wechsler Test of Adult Reading: WTAR. Psychological Corporation
7.
go back to reference Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. San Antonio Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. San Antonio
8.
go back to reference Pullens MJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 19(11):1127–1138CrossRefPubMed Pullens MJ, De Vries J, Roukema JA (2010) Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 19(11):1127–1138CrossRefPubMed
10.
go back to reference Von Ah D, Tallman EF (2015) Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manage 49(4):697–706. doi:10.1016/j.jpainsymman.2014.08.012 CrossRef Von Ah D, Tallman EF (2015) Perceived cognitive function in breast cancer survivors: evaluating relationships with objective cognitive performance and other symptoms using the functional assessment of cancer therapy-cognitive function instrument. J Pain Symptom Manage 49(4):697–706. doi:10.​1016/​j.​jpainsymman.​2014.​08.​012 CrossRef
11.
go back to reference Brenner RP, Reynolds CF, Ulrich RF (1988) Diagnostic efficacy of computerized spectral versus visual EEG analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol 69(2):110–117CrossRefPubMed Brenner RP, Reynolds CF, Ulrich RF (1988) Diagnostic efficacy of computerized spectral versus visual EEG analysis in elderly normal, demented and depressed subjects. Electroencephalogr Clin Neurophysiol 69(2):110–117CrossRefPubMed
12.
go back to reference Brenner RP, Reynolds CF, Ulrich RF (1989) EEG findings in depressive pseudodementia and dementia with secondary depression. Electroencephalogr Clin Neurophysiol 72(4):298–304CrossRefPubMed Brenner RP, Reynolds CF, Ulrich RF (1989) EEG findings in depressive pseudodementia and dementia with secondary depression. Electroencephalogr Clin Neurophysiol 72(4):298–304CrossRefPubMed
14.
go back to reference Klass DW, Brenner RP (1995) Electroencephalography of the elderly. J Clin Neurophysiol 12(2):116–131CrossRefPubMed Klass DW, Brenner RP (1995) Electroencephalography of the elderly. J Clin Neurophysiol 12(2):116–131CrossRefPubMed
17.
go back to reference Reichert JL, Kober SE, Witte M, Neuper C, Wood G (2016) Age-related effects on verbal and visuospatial memory are mediated by theta and alpha II rhythms. Int J Psychophysiol 99:67–78CrossRefPubMed Reichert JL, Kober SE, Witte M, Neuper C, Wood G (2016) Age-related effects on verbal and visuospatial memory are mediated by theta and alpha II rhythms. Int J Psychophysiol 99:67–78CrossRefPubMed
18.
go back to reference Mathan S, Smart A, Ververs T, Feuerstein M (2010) Towards an index of cognitive efficacy EEG-based estimation of cognitive load among individuals experiencing cancer-related cognitive decline. Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference 2010:6595–6598. doi:10.1109/iembs.2010.5627126 Mathan S, Smart A, Ververs T, Feuerstein M (2010) Towards an index of cognitive efficacy EEG-based estimation of cognitive load among individuals experiencing cancer-related cognitive decline. Conference proceedings : Annual International Conference of the IEEE Engineering in Medicine and Biology Society IEEE Engineering in Medicine and Biology Society Annual Conference 2010:6595–6598. doi:10.​1109/​iembs.​2010.​5627126
19.
go back to reference Kreukels BP, Hamburger HL, de Ruiter MB, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008) ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol Off J Int Federation Clin Neurophysiol 119(3):533–541. doi:10.1016/j.clinph.2007.11.011 CrossRef Kreukels BP, Hamburger HL, de Ruiter MB, van Dam FS, Ridderinkhof KR, Boogerd W, Schagen SB (2008) ERP amplitude and latency in breast cancer survivors treated with adjuvant chemotherapy. Clin Neurophysiol Off J Int Federation Clin Neurophysiol 119(3):533–541. doi:10.​1016/​j.​clinph.​2007.​11.​011 CrossRef
20.
go back to reference Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS (2005) Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 94(1):53–61. doi:10.1007/s10549-005-7093-3 CrossRefPubMed Kreukels BP, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FS (2005) Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 94(1):53–61. doi:10.​1007/​s10549-005-7093-3 CrossRefPubMed
21.
go back to reference Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF (2014) Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology 23(6):713–715. doi:10.1002/pon.3487 CrossRefPubMed Hunter AM, Kwan L, Ercoli LM, Mills BK, Cook IA, Ganz PA, Leuchter AF (2014) Quantitative electroencephalography biomarkers of cognitive complaints after adjuvant therapy in breast cancer survivors: a pilot study. Psychooncology 23(6):713–715. doi:10.​1002/​pon.​3487 CrossRefPubMed
22.
go back to reference Ercoli L, Petersen L, Hunter A, Castellon S, Kwan L, Kahn-Mills B, Embree L, Cernin P, Leuchter A, Ganz P (2015) Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psycho-Oncology. 24(11):1360–1367CrossRefPubMed Ercoli L, Petersen L, Hunter A, Castellon S, Kwan L, Kahn-Mills B, Embree L, Cernin P, Leuchter A, Ganz P (2015) Cognitive rehabilitation group intervention for breast cancer survivors: results of a randomized clinical trial. Psycho-Oncology. 24(11):1360–1367CrossRefPubMed
23.
go back to reference Buchanan ND, Dasari S, Rodriguez JL, Smith JL, Hodgson ME, Weinberg CR, Sandler DP (2015) Post-treatment neurocognition and psychosocial care among breast cancer survivors. Am J Prev Med 49(6):S498–S508CrossRefPubMedPubMedCentral Buchanan ND, Dasari S, Rodriguez JL, Smith JL, Hodgson ME, Weinberg CR, Sandler DP (2015) Post-treatment neurocognition and psychosocial care among breast cancer survivors. Am J Prev Med 49(6):S498–S508CrossRefPubMedPubMedCentral
24.
go back to reference Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin 66(1):43–73. doi:10.3322/caac.21319 CrossRefPubMed Runowicz CD, Leach CR, Henry NL, Henry KS, Mackey HT, Cowens-Alvarado RL, Cannady RS, Pratt-Chapman ML, Edge SB, Jacobs LA, Hurria A, Marks LB, LaMonte SJ, Warner E, Lyman GH, Ganz PA (2016) American Cancer Society/American Society of clinical oncology breast cancer survivorship care guideline. CA Cancer J Clin 66(1):43–73. doi:10.​3322/​caac.​21319 CrossRefPubMed
25.
go back to reference Wefel JS, Kesler SR, Noll KR, Schagen SB (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65(2):123–138. doi:10.3322/caac.21258 CrossRefPubMed Wefel JS, Kesler SR, Noll KR, Schagen SB (2015) Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults. CA Cancer J Clin 65(2):123–138. doi:10.​3322/​caac.​21258 CrossRefPubMed
27.
go back to reference Strauss E, Sherman EMS, Spreen O (2006) Verbal Fluency. In: A compendium of neuropsychological tests. 3rd edn. Oxford University Press, New York Strauss E, Sherman EMS, Spreen O (2006) Verbal Fluency. In: A compendium of neuropsychological tests. 3rd edn. Oxford University Press, New York
28.
go back to reference Heaton R, Miller SW, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz Heaton R, Miller SW, Taylor MJ, Grant I (2004) Revised comprehensive norms for an expanded Halstead-Reitan battery: demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources, Lutz
30.
go back to reference Delis DC, Kaplan E, Kramer JH (2000) California Verbal Learning Test-II, 2nd edn. The Psych. Corp, San Antonio Delis DC, Kaplan E, Kramer JH (2000) California Verbal Learning Test-II, 2nd edn. The Psych. Corp, San Antonio
31.
go back to reference Wechsler D (2009) Wechsler Memory Scale, 4th edn. Pearson, San Antonio Wechsler D (2009) Wechsler Memory Scale, 4th edn. Pearson, San Antonio
32.
go back to reference Benedict RH (1997) Brief visuospatial memory test—revised. Psychological Assessment Resources Inc, Odessa Benedict RH (1997) Brief visuospatial memory test—revised. Psychological Assessment Resources Inc, Odessa
33.
go back to reference Shin M-S, Park S-Y, Park S-R, Seol S-H, Kwon JS (2006) Clinical and empirical applications of the Rey-Osterrieth complex figure test. Nat Protoc 1(2):892–899CrossRefPubMed Shin M-S, Park S-Y, Park S-R, Seol S-H, Kwon JS (2006) Clinical and empirical applications of the Rey-Osterrieth complex figure test. Nat Protoc 1(2):892–899CrossRefPubMed
34.
go back to reference Wechsler D (2008) Wechsler adult intelligence scale, 4th edn. NCS Pearson, San Antonio Wechsler D (2008) Wechsler adult intelligence scale, 4th edn. NCS Pearson, San Antonio
35.
go back to reference Gronwell DMA (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367–373CrossRef Gronwell DMA (1977) Paced auditory serial-addition task: a measure of recovery from concussion. Percept Mot Skills 44:367–373CrossRef
Metadata
Title
Evaluating cognitive complaints in breast cancer survivors with the FACT-Cog and quantitative electroencephalography
Authors
Kathleen Van Dyk
Aimee M. Hunter
Linda Ercoli
Laura Petersen
Andrew F. Leuchter
Patricia A. Ganz
Publication date
01-11-2017
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2017
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-017-4390-6

Other articles of this Issue 1/2017

Breast Cancer Research and Treatment 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine